Improving precision medicine using individual patient data from trials
نویسندگان
چکیده
منابع مشابه
Improving precision medicine using individual patient data from trials.
© 2016 Joule Inc. or its licensors CMAJ 1 Our first commitment as clinicians is to our patients as individuals. This understanding lies at the heart of the precision medicine initiative, which aims to customize treatments based not only on a patient’s clinical picture but also on their genetic, demographic and environmental profile.1 Clinical trials are rigid by design, typically assessing the ...
متن کاملEffectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta-analysis
OBJECTIVE To determine whether vertebroplasty is more effective than placebo for patients with pain of recent onset (≤ 6 weeks) or severe pain (score ≥ 8 on 0-10 numerical rating scale). DESIGN Meta-analysis of combined individual patient level data. SETTING Two multicentred randomised controlled trials of vertebroplasty; one based in Australia, the other in the United States. PARTICIPANT...
متن کاملPrecision medicine in myasthenia graves: begin from the data precision.
Myasthenia gravis (MG) is a prototypic autoimmune disease with overt clinical and immunological heterogeneity. The data of MG is far from individually precise now, partially due to the rarity and heterogeneity of this disease. In this review, we provide the basic insights of MG data precision, including onset age, presenting symptoms, generalization, thymus status, pathogenic autoantibodies, mu...
متن کاملA Precision Medicine Approach to Oxytocin Trials.
In this chapter, we introduce a new area of social pharmacology that encompasses the study of the role of neuromodulators in modulating a wide range of social behaviors and brain function, with the interplay of genetic and epigenetic factors. There are increasing evidences for the role of the neuropeptide oxytocin in modulating a wide range of social behaviors, in reducing anxiety, and in impac...
متن کاملMeta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.
BACKGROUND In clinical trials following individuals over a period of time, the same assessment may be made at a number of time points during the course of the trial. Our review of current practice for handling longitudinal data in Cochrane systematic reviews shows that the most frequently used approach is to ignore the correlation between repeated observations and to conduct separate meta-analy...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Medical Association Journal
سال: 2016
ISSN: 0820-3946,1488-2329
DOI: 10.1503/cmaj.160267